- Conditions
- Total Joint Arthroplasty, Periprosthetic Joint Infections
- Interventions
- Blood Draw or Saliva/Cheek Cell Sample:
- Genetic
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 150 participants
- Timeline
- 2018 – 2028
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
Source: ClinicalTrials.gov public record
Updated Mar 18, 2026 · Synced May 21, 2026, 10:57 PM EDT